Signaturefd, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Signaturefd, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$144.95 - $152.29 $34,063 - $35,788	235 Added 185.04%	362 $55,000
Q2 2022 Aug 10, 2022	BUY	$83.14 - $145.99 $6,983 - $12,263	84 Added 195.35%	127 $19,000
Q1 2022 May 02, 2022	BUY	$110.08 - $142.92 $3,632 - $4,716	33 Added 330.0%	43 $5,000
Q4 2021 Jan 25, 2022	BUY	$99.73 - $148.48 $997 - $1,484	10 New	10 $1,000
Q1 2021 Apr 30, 2021	SELL	$64.07 - $91.75 $961 - $1,376	-15 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$65.07 - $98.24 $976 - $1,473	15 New	15 $1,000
Q3 2020 Nov 03, 2020	SELL	$59.04 - $77.95 $4,428 - $5,846	-75 Closed	0 $0
Q2 2020 Jul 30, 2020	BUY	$29.01 - $74.23 $2,175 - $5,567	75 New	75 $5,000

785K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

Stay updated on Signaturefd, LLC with notifications on news.